Does patient engagement affect IBD patients’ health-related quality of life? Findings from a cross-sectional study among people with inflammatory bowel diseases
Tóm tắt
Patients diagnosed with inflammatory bowel disease (IBD) are required to deal with the unpredictability of this clinical condition, which is associated with poorer health-related quality of life (HRQoL) compared to other clinical conditions. Patient engagement is currently demonstrated to relate with chronic patients’ HRQoL, but few studies have been conducted among this population. A cross-sectional study was conducted among 1176 IBD patients. Data were collected on participants’ HRQoL (SIBD-Q) and patient engagement (PHE-s®). Regression analysis was used to examine the effects of patient engagement on HRQoL. About the half of the sample (47%) reported a low patient engagement level. 30% of the sample reported a low level of HRQoL. Psycho-emotional functioning resulted to be the aspect of HRQoL most impacted in the 37% of the sample. The regression model showed that PHE-s® is significantly related to the SIBD-Q total score (B = .585; p < .001; R squared = .343) and to the subscales’ scores—systemic symptoms (B = .572; p < .001; R squared = .327), bowel symptoms (B = .482; p < .001; R squared = .232), social (B = .485; p < .001; R squared = .234) and psycho-emotional (B = .607; p < .001; R squared = .369) functioning. Patients who are engaged in their IBD care pathway are more likely to report higher level of HRQoL, thus offering clues to potential therapeutic approaches to ameliorating IBD patients’ wellbeing. As this is a modifiable factor, screening for patient health engagement levels, coupled with appropriate interventions, could improve care, and ultimately improve HRQoL outcomes among IBD patients.
Tài liệu tham khảo
Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142:46‐54.e42; quiz e30.
Loftus EV. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology. 2004;126:1504–17.
Lakatos P-L. Recent trends in the epidemiology of inflammatory bowel diseases: up or down? World J Gastroenterol. 2006;12:6102–8.
Tragnone A, Corrao G, Miglio F, Caprilli R LG. Incidence of inflammatory bowel disease in Italy: a nationwide population-based study. Gruppo Italiano per lo Studio del Colon e del Retto (GISC). Int J Epidemiol. 1996;25(5):
Mark A Peppercorn. Definition, epidemiology, and risk factors in inflammatory bowel disease-UpToDate. UpToDate. 2018;
McCormick JB, Hammer RR, Farrell RM, Geller G, James KM, Loftus E V., et al. Experiences of patients with chronic gastrointestinal conditions: In their own words. Health Qual Life Outcomes. 2012;
Rocchi A, Benchimol EI, Bernstein CN, Bitton A, Feagan B, Panaccione R, et al. Inflammatory bowel disease: A Canadian burden of illness review. Gastroenterol: Can. J; 2012.
Ciccocioppo R, Klersy C, Russo ML, Valli M, Boccaccio V, Imbesi V, et al. Validation of the Italian translation of the Inflammatory Bowel Disease Questionnaire. Dig Liver Dis Editrice Gastroenterologica Italiana. 2011;43:535–41.
Boye B, Lundin KEA, Jantschek G, Leganger S, Mokleby K, Tangen T, et al. INSPIRE study: Does stress management improve the course of inflammatory bowel disease and disease-specific quality of life in distressed patients with ulcerative colitis or crohn’s disease? Inflamm Bowel Dis: A randomized controlled trial; 2011.
Crohn’s & Colitis Foundation of America. The Facts About Inflammatory Bowel Diseases. Inflamm Bowel Dis. 2014;
van der E, Vlachonikolis IG, Munkholm P, Nijman J, Bernklev T, Politi P, et al. The role of quality of care in health-related quality of life in patients with IBD. Inflamm Bowel Dis. 2004;10:392–8.
Barello S, Leone D, Danese S, Vegni E. Inflammatory bowel diseases and psychological issues: A new approach for a systematic analysis of the academic debate. Psychol Health Med [Internet]. 2013;37–41. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24215557
Sajadinejad MS, Asgari K, Molavi H, Kalantari M, Adibi P. Psychological issues in inflammatory bowel disease: An overview. Pract: Gastroenterol. Res; 2012.
Jordan C, Sin J, Fear NT, Chalder T. A systematic review of the psychological correlates of adjustment outcomes in adults with inflammatory bowel disease. Rev: Clin. Psychol; 2016.
Jedel S, Hood MM, Keshavarzian A. Getting personal: A review of sexual functioning, body image, and their impact on quality of life in patients with inflammatory bowel disease. Bowel Dis: Inflamm; 2015.
Forestier B, Anthoine E, Reguiai Z, Fohrer C, Blanchin M. A systematic review of dimensions evaluating patient experience in chronic illness. Health Qual Life Outcomes. 2019;2:1–14.
Sainsbury A, Heatley RV. Review article: Psychosocial factors in the quality of life of patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2005;21:499–508.
McCombie AM, Mulder RT, Gearry RB. How IBD patients cope with IBD: A systematic review. J. Crohn’s Colitis. 2013.
Triantafillidis JK, Merikas E, Gikas A. Psychological factors and stress in inflammatory bowel disease. Hepatol: Expert Rev. Gastroenterol; 2013.
Trindade IA, Ferreira C, Pinto-Gouveia J. Chronic illness-related shame and experiential avoidance mediate the impact of IBD symptomatology on depression. Eur Psychiatry. 2016;
Goodhand J, Rampton D. Psychological stress and coping in IBD. Gut. 2008.
Vidal A, Gomez-Gil E, Sans M, Portella MJ, Salamero M, Piqué JM, et al. Health-related quality of life in inflammatory bowel disease patients: The role of psychopathology and personality. Inflamm Bowel Dis. 2008;
Moreno-Jiménez, B., Blanco, B. L., Rodríguez-Muñoz, A., & Hernández EG. The influence of personality factors on health-related quality of life of patients with inflammatory bowel disease. J Psychosom Res. 2007;62(1),:39–46.
Verissimo, R., Mota-Cardoso, R., & Taylor G. Relationships between alexithymia, emotional control, and quality of life in patients with inflammatory bowel disease. Psychother Psychosom. 1998;67(2),:75–80.
Hall NJ, Rubin GP, Dougall A, Hungin APS, Neely J. The Fight for ‘Health-related Normality’: A Qualitative Study of the Experiences of Individuals Living with Established Inflammatory Bowel Disease (IBD). J Health Psychol. 2005;10:443–55.
Hou JK, Lee D, Lewis J. Diet and Inflammatory Bowel Disease: Review of Patient-Targeted Recommendations. Clin Gastroenterol Hepatol. 2014;
Horne R, Parham R, Driscoll R, Robinson A. Patient’s attitudes to medicines and adherence to maintenance treatment in inflammatory bowel disease. Inflamm Bowel Dis. 2009;
Friedman S, Cheifetz AS, Farraye FA, Banks PA, Makrauer FL, Burakoff R, et al. Doctor message can alter patients’ behavior and attitudes regarding inflammatory bowel disease and colon cancer. Inflamm Bowel Dis. 2012;
Graffigna G, Barello S. Spotlight on the Patient Health Engagement model (PHE model): a psychosocial theory to understand people’s meaningful engagement in their own health care. Patient Prefer Adherence. 2018;12:1261–71.
Graffigna G, Barello S, Bonanomi A. The role of Patient Health Engagement model (PHE-model) in affecting patient activation and medication adherence: A structural equation model. PLoS One. 2017;12.
Graffigna G, Barello S, Bonanomi A, Riva G. Factors affecting patients’ online health information-seeking behaviors: the role of the Patient Health Engagement (PHE) Model. Patient Educ Couns. 2017;
Hibbard JH, Mahoney ER, Stock R, Tusler M. Do increases in patient activation result in improved self-management behaviors? Health Serv Res. 2007;42:1443–63.
Greene J, Hibbard JH, Sacks R, Overton V, Parrotta CD. When patient activation levels change, health outcomes and costs change, too. Health Aff (Millwood) [Internet]. Project HOPE; 2015 [cited 2015 Nov 16];34:431–7. Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-84924629092&partnerID=tZOtx3y1
Shah SL, Siegel CA. Increasing Patient Activation Could Improve Outcomes for Patients with Inflammatory Bowel Disease. Bowel Dis: Inflamm; 2015.
Oles SK, Fukui S, Rand KL, Salyers MP. The relationship between hope and patient activation in consumers with schizophrenia: Results from longitudinal analyses. Psychiatry Res [Internet]. Elsevier Ireland Ltd; 2015 [cited 2015 Oct 5];228:272–6. Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-84938751608&partnerID=tZOtx3y1
Baars JE, Markus T, Kuipers EJ, Van Der Woude CJ. Patients’ preferences regarding shared decision-making in the treatment of inflammatory bowel disease: Results from a patient-empowerment study. Digestion. 2010;
Munson GW, Wallston KA, Dittus RS, Speroff T, Roumie CL. Activation and perceived expectancies: Correlations with health outcomes among veterans with inflammatory bowel disease. J Gen Intern Med. 2009;
Goldring AB, Taylora SE, Kemeny ME, Anton PA. Impact of health beliefs, quality of life, and the physician-patient relationship on the treatment intentions of inflammatory bowel disease patients. Heal Psychol. 2002;
Magnezi R, Glasser S, Shalev H, Sheiber A, Reuveni H. Patient activation, depression and quality of life. Patient Educ Couns. 2014;94:432–7.
Barello S, Graffigna G. Engaging patients to recover life projectuality: an Italian cross-disease framework. Qual Life Res. 2015;24.
Moser DK, Dickson V, Jaarsma T, Lee C, Stromberg A, Riegel B. Role of self-care in the patient with heart failure. Curr Cardiol Rep [Internet]. 2012 [cited 2013 Dec 28];14:265–75. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22437374
Graffigna G, Barello S, Bonanomi A, Lozza E. Measuring patient engagement: development and psychometric properties of the Patient Health Engagement (PHE) Scale. Front Psychol [Internet]. Frontiers Research Foundation; 2015 [cited 2016 Jan 5];6:274. Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-84926457655&partnerID=tZOtx3y1
Graffigna G, Barello S. Patient Health Engagement (PHE) model in enhanced recovery after surgery (ERAS): Monitoring patients’ engagement and psychological resilience in minimally invasive thoracic surgery. J Thorac Dis. 2018;10.
Guyatt, Gordon; Mitchell, Alba; Ivrine, E.Jan; Williams, Nancy; Goodacre, Robert; Tompkins C. A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology. 1989;96:804–10.
Chen XL, Zhong L huan, Wen Y, Liu TW, Li XY, Hou ZK, et al. Inflammatory bowel disease-specific health-related quality of life instruments: A systematic review of measurement properties. Health Qual Life Outcomes. Health and Quality of Life Outcomes; 2017;15:1–13.
Mahalli AAE, Alharthi HMA. Assessment of health-related quality of life of patients with inflammatory bowel diseases in Eastern Province. Saudi Arabia J Infect Public Health. 2017;10:93–101.
Blanchard JF1, Bernstein CN, Wajda A RP. Small-area variations and sociodemographic correlates for the incidence of Crohn’s disease and ulcerative colitis. Am J Epidemiol. 154(4):328–35.
Sonnenberg A. Demographic Characteristics of Hospitalized IBD Patients. Dig Dis Sci. 54:2449.
Habibi, F., Habibi, M. E., Gharavinia, A., Mahdavi, S. B., Akbarpour, M. J., Baghaei, A., & Emami MH. Quality of life in inflammatory bowel disease patients: A cross-sectional study. J Res Med Sci. 2017;22, 104. d.
Lichtenstein GR, Yan S, Bala M, Hanauer S. Remission in patients with Crohn’s disease is associated with improvement in employment and quality of life and a decrease in hospitalizations and surgeries. Am J Gastroenterol. 2004;
Barnes EL, Long MD, Kappelman MD, Martin CF, Sandler RS. High Patient Activation Is Associated With Remission in Patients With Inflammatory Bowel Disease. Inflamm Bowel Dis [Internet]. 2018;XX:1–7. Available from: https://academic.oup.com/ibdjournal/advance-article/doi/https://doi.org/10.1093/ibd/izy378/5257738
Magnezi R, Glasser S, Shalev H, Sheiber A, Reuveni H. Patient activation, depression and quality of life. Patient Educ Couns [Internet]. 2014 [cited 2016 Jan 3];94:432–7. Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-84894032728&partnerID=tZOtx3y1
Hochhalter AK, Song J, Rush J, Sklar L, Stevens A. Making the Most of Your Healthcare intervention for older adults with multiple chronic illnesses. Patient Educ Couns [Internet]. 2010 [cited 2015 Nov 25];81:207–13. Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-77957284212&partnerID=tZOtx3y1
Druss BG, Zhao L, von Esenwein SA, Bona JR, Fricks L, Jenkins-Tucker S, et al. The Health and Recovery Peer (HARP) Program: a peer-led intervention to improve medical self-management for persons with serious mental illness. Schizophr Res [Internet]. 2010 [cited 2015 Sep 18];118:264–70. Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-77952107604&partnerID=tZOtx3y1
Dodson SE, Ruisinger JF, Howard PA, Hare SE, Barnes BJ. Servicios de gestión de la medicación en farmacia comunitaria: Impacto financiero para los pacientes. Pharm Pract (Granada) [Internet]. 2012;10:119–24. Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-84866537753&partnerID=tZOtx3y1
Barello, S., Guida, E., Bonanomi, A., Menichetti, J., Leone, S., Previtali, E., & Graffigna, G. (2020). We-care ibd score: assessing high-quality care in the perspective of patients with inflammatory bowel diseases. Journal of Crohn's and Colitis. jjaa174, https://doi.org/https://doi.org/10.1093/ecco-jcc/jjaa174